These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22778257)

  • 1. Ca(2+)/calmodulin-dependent protein kinase IIα (αCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome.
    Steinkellner T; Yang JW; Montgomery TR; Chen WQ; Winkler MT; Sucic S; Lubec G; Freissmuth M; Elgersma Y; Sitte HH; Kudlacek O
    J Biol Chem; 2012 Aug; 287(35):29627-35. PubMed ID: 22778257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo amphetamine action is contingent on αCaMKII.
    Steinkellner T; Mus L; Eisenrauch B; Constantinescu A; Leo D; Konrad L; Rickhag M; Sørensen G; Efimova EV; Kong E; Willeit M; Sotnikova TD; Kudlacek O; Gether U; Freissmuth M; Pollak DD; Gainetdinov RR; Sitte HH
    Neuropsychopharmacology; 2014 Oct; 39(11):2681-93. PubMed ID: 24871545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine action at the cocaine- and antidepressant-sensitive serotonin transporter is modulated by αCaMKII.
    Steinkellner T; Montgomery TR; Hofmaier T; Kudlacek O; Yang JW; Rickhag M; Jung G; Lubec G; Gether U; Freissmuth M; Sitte HH
    J Neurosci; 2015 May; 35(21):8258-71. PubMed ID: 26019340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux.
    Foster JD; Yang JW; Moritz AE; Challasivakanaka S; Smith MA; Holy M; Wilebski K; Sitte HH; Vaughan RA
    J Biol Chem; 2012 Aug; 287(35):29702-12. PubMed ID: 22722938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport.
    Fog JU; Khoshbouei H; Holy M; Owens WA; Vaegter CB; Sen N; Nikandrova Y; Bowton E; McMahon DG; Colbran RJ; Daws LC; Sitte HH; Javitch JA; Galli A; Gether U
    Neuron; 2006 Aug; 51(4):417-29. PubMed ID: 16908408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine.
    Wheeler DS; Underhill SM; Stolz DB; Murdoch GH; Thiels E; Romero G; Amara SG
    Proc Natl Acad Sci U S A; 2015 Dec; 112(51):E7138-47. PubMed ID: 26553986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential targeting of the dopamine transporter to recycling or degradative pathways during amphetamine- or PKC-regulated endocytosis in dopamine neurons.
    Hong WC; Amara SG
    FASEB J; 2013 Aug; 27(8):2995-3007. PubMed ID: 23612789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants.
    Mergy MA; Gowrishankar R; Gresch PJ; Gantz SC; Williams J; Davis GL; Wheeler CA; Stanwood GD; Hahn MK; Blakely RD
    Proc Natl Acad Sci U S A; 2014 Nov; 111(44):E4779-88. PubMed ID: 25331903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release.
    Rickhag M; Owens WA; Winkler MT; Strandfelt KN; Rathje M; Sørensen G; Andresen B; Madsen KL; Jørgensen TN; Wörtwein G; Woldbye DPD; Sitte H; Daws LC; Gether U
    J Biol Chem; 2013 Sep; 288(38):27534-27544. PubMed ID: 23884410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine.
    Napolitano F; Bonito-Oliva A; Federici M; Carta M; Errico F; Magara S; Martella G; Nisticò R; Centonze D; Pisani A; Gu HH; Mercuri NB; Usiello A
    J Neurosci; 2010 Aug; 30(33):11043-56. PubMed ID: 20720111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic Ric GTPase activity impacts amphetamine sensitivity and sleep quality in a dopamine transporter-dependent manner in Drosophila melanogaster.
    Fagan RR; Kearney PJ; Luethi D; Bolden NC; Sitte HH; Emery P; Melikian HE
    Mol Psychiatry; 2021 Dec; 26(12):7793-7802. PubMed ID: 34471250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine-induced reverse transport of dopamine does not require cytosolic Ca
    Støier JF; Konomi-Pilkati A; Apuschkin M; Herborg F; Gether U
    J Biol Chem; 2023 Aug; 299(8):105063. PubMed ID: 37468107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding.
    Challasivakanaka S; Zhen J; Smith ME; Reith MEA; Foster JD; Vaughan RA
    J Biol Chem; 2017 Nov; 292(46):19066-19075. PubMed ID: 28939767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase Cbeta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice.
    Chen R; Furman CA; Zhang M; Kim MN; Gereau RW; Leitges M; Gnegy ME
    J Pharmacol Exp Ther; 2009 Mar; 328(3):912-20. PubMed ID: 19098163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gβγ subunit activation promotes dopamine efflux through the dopamine transporter.
    Garcia-Olivares J; Baust T; Harris S; Hamilton P; Galli A; Amara SG; Torres GE
    Mol Psychiatry; 2017 Dec; 22(12):1673-1679. PubMed ID: 28894302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular methamphetamine prevents the dopamine-induced enhancement of neuronal firing.
    Saha K; Sambo D; Richardson BD; Lin LM; Butler B; Villarroel L; Khoshbouei H
    J Biol Chem; 2014 Aug; 289(32):22246-57. PubMed ID: 24962577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation.
    Sakrikar D; Mazei-Robison MS; Mergy MA; Richtand NW; Han Q; Hamilton PJ; Bowton E; Galli A; Veenstra-Vanderweele J; Gill M; Blakely RD
    J Neurosci; 2012 Apr; 32(16):5385-97. PubMed ID: 22514303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.
    Binda F; Dipace C; Bowton E; Robertson SD; Lute BJ; Fog JU; Zhang M; Sen N; Colbran RJ; Gnegy ME; Gether U; Javitch JA; Erreger K; Galli A
    Mol Pharmacol; 2008 Oct; 74(4):1101-8. PubMed ID: 18617632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.
    Gnegy ME; Khoshbouei H; Berg KA; Javitch JA; Clarke WP; Zhang M; Galli A
    Mol Pharmacol; 2004 Jul; 66(1):137-43. PubMed ID: 15213305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems.
    Hall FS; Itokawa K; Schmitt A; Moessner R; Sora I; Lesch KP; Uhl GR
    Neuropharmacology; 2014 Jan; 76 Pt A(0 0):146-55. PubMed ID: 23978383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.